UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A Multi-Faceted Binding Assessment of Aptamers Targeting the SARS-CoV-2 Spike Protein

International journal of molecular sciences, 2024-05, Vol.25 (9), p.4642

2024

Volltextzugriff (PDF)

Transgene expression knock-down in recombinant Modified Vaccinia virus Ankara vectors improves genetic stability and sustained transgene maintenance across multiple passages

Frontiers in immunology, 2024-02, Vol.15, p.1338492-1338492

2024

Volltextzugriff (PDF)

Wann kommt endlich eine Impfung gegen HIV?

MMW Fortschritte der Medizin, 2022-06, Vol.164 (Suppl 2), p.30-33

2022

Volltextzugriff (PDF)

Coronavirus Pseudotypes for All Circulating Human Coronaviruses for Quantification of Cross-Neutralizing Antibody Responses

Viruses, 2021-08, Vol.13 (8), p.1579

2021

Volltextzugriff (PDF)

Preferential Expansion of HPV16 E1-Specific T Cells from Healthy Donors' PBMCs after Ex Vivo Immunization with an E1E2E6E7 Fusion Antigen

Cancers, 2023-12, Vol.15 (24), p.5863

2023

Volltextzugriff (PDF)

Design and Immunological Validation of Macaca fascicularis Papillomavirus Type 3 Based Vaccine Candidates in Outbred Mice: Basis for Future Testing of a Therapeutic Papillomavirus Vaccine in NHPs

Frontiers in immunology, 2021-10, Vol.12, p.761214-761214

2021

Volltextzugriff (PDF)

Comprehensive analysis of interactions between the Src-associated protein in mitosis of 68 kDa and the human Src-homology 3 proteome

PloS one, 2012-06, Vol.7 (6), p.e38540-e38540

2012

Volltextzugriff (PDF)

Glycan masking of a non-neutralising epitope enhances neutralising antibodies targeting the RBD of SARS-CoV-2 and its variants

Frontiers in immunology, 2023-02, Vol.14, p.1118523-1118523

2023

Volltextzugriff (PDF)

Potency and durability of T and B cell immune responses after homologous and heterologous vector delivery of a trimer-stabilized, membrane-displayed HIV-1 clade ConC Env protein

Frontiers in immunology, 2023, Vol.14, p.1270908-1270908

2023

Volltextzugriff (PDF)

The HIV 5′ Gag Region Displays a Specific Nucleotide Bias Regulating Viral Splicing and Infectivity

Viruses, 2021-05, Vol.13 (6), p.997

2021

Volltextzugriff (PDF)

Comparative Immunogenicity of COVID-19 Vaccines in a Population-Based Cohort Study with SARS-CoV-2-Infected and Uninfected Participants

Vaccines (Basel), 2022-02, Vol.10 (2), p.324

2022

Volltextzugriff (PDF)

Heterologous Combination of VSV-GP and NYVAC Vectors Expressing HIV-1 Trimeric gp145 Env as Vaccination Strategy to Induce Balanced B and T Cell Immune Responses

Frontiers in immunology, 2019-12, Vol.10, p.2941-2941

2019

Volltextzugriff (PDF)

Computationally designed Spike antigens induce neutralising responses against the breadth of SARS-COV-2 variants

npj vaccines, 2024-09, Vol.9 (1), p.164-9, Article 164

2024

Volltextzugriff (PDF)

Dürfen wir noch auf eine HIV-Impfung hoffen?

MMW Fortschritte der Medizin, 2018-06, Vol.160 (Suppl 2), p.24-27

2018

Volltextzugriff (PDF)

Influenza A (N1-N9) and Influenza B (B/Victoria and B/Yamagata) Neuraminidase Pseudotypes as Tools for Pandemic Preparedness and Improved Influenza Vaccine Design

Vaccines (Basel), 2022-09, Vol.10 (9), p.1520

2022

Volltextzugriff (PDF)

Exploiting Pan Influenza A and Pan Influenza B Pseudotype Libraries for Efficient Vaccine Antigen Selection

Vaccines (Basel), 2021-07, Vol.9 (7), p.741

2021

Volltextzugriff (PDF)

Wann kommt endlich eine Impfung gegen HIV?

MMW Fortschritte der Medizin, 2022-01, Vol.164 (Suppl 2), p.30-33

2022

Volltextzugriff (PDF)

Particle-based delivery of the HIV envelope protein

Current opinion in HIV & AIDS, 2017-05, Vol.12 (3), p.265

2017

Volltextzugriff (PDF)

Particle-based delivery of the HIV envelope protein

Current opinion in HIV & AIDS, 2017-05, Vol.12 (3), p.265-271

2017

Volltextzugriff (PDF)

A serum-stable RNA aptamer specific for SARS-CoV-2 neutralizes viral entry

Proceedings of the National Academy of Sciences - PNAS, 2021-12, Vol.118 (50), p.1

2021

Volltextzugriff (PDF)

Development of a vaccine against HIV: is this aim accomplishable?

MMW Fortschritte der Medizin, 2013-06, Vol.155 Suppl 1, p.36-39

2013

Volltextzugriff (PDF)

Interplay of Promoter Usage and Intragenic CpG Content: Impact on GFP Reporter Gene Expression

Human gene therapy, 2015-12, Vol.26 (12), p.826-840

2015

Volltextzugriff (PDF)

SARS-CoV-2 Spike Protein Stabilized in the Closed State Induces Potent Neutralizing Responses

Journal of virology, 2021-07, Vol.95 (15), p.e0020321-e0020321

2021

Volltextzugriff (PDF)

1 – 25 von 51

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(46)
Mit Volltextzugriff
(43)

Publikationsform

Sprache

Englisch
(46)
Deutsch
(5)

Erscheinungsjahr

n.n

Thema

Science & Technology
(36)
Life Sciences & Biomedicine
(29)
Humans
(22)
Animals
(17)
Immunology
(14)
Virology
(10)
Proteins
(9)
Antigens
(8)
Medicine, Research & Experimental
(8)
Mice
(8)
Research & Experimental Medicine
(8)
Aids Vaccines - Immunology
(7)
Vaccines
(7)
Vaccines And Antiviral Agents
(7)
Antibodies
(6)
Hiv-1 - Immunology
(6)
Human Immunodeficiency Virus
(6)
Infections
(6)
Severe Acute Respiratory Syndrome Coronavirus 2
(6)
Vaccination
(6)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

A Multi-Faceted Binding Assessment of Aptamers Targeting the SARS-CoV-2 Spike Protein

Transgene expression knock-down in recombinant Modified Vaccinia virus Ankara vectors improves genetic stability and sustained transgene maintenance across multiple passages

Wann kommt endlich eine Impfung gegen HIV?

Coronavirus Pseudotypes for All Circulating Human Coronaviruses for Quantification of Cross-Neutralizing Antibody Responses

Preferential Expansion of HPV16 E1-Specific T Cells from Healthy Donors' PBMCs after Ex Vivo Immunization with an E1E2E6E7 Fusion Antigen

Design and Immunological Validation of Macaca fascicularis Papillomavirus Type 3 Based Vaccine Candidates in Outbred Mice: Basis for Future Testing of a Therapeutic Papillomavirus Vaccine in NHPs

Comprehensive analysis of interactions between the Src-associated protein in mitosis of 68 kDa and the human Src-homology 3 proteome

Glycan masking of a non-neutralising epitope enhances neutralising antibodies targeting the RBD of SARS-CoV-2 and its variants

Potency and durability of T and B cell immune responses after homologous and heterologous vector delivery of a trimer-stabilized, membrane-displayed HIV-1 clade ConC Env protein

The HIV 5′ Gag Region Displays a Specific Nucleotide Bias Regulating Viral Splicing and Infectivity

Early and Long-Term HIV-1 Immunogenicity Induced in Macaques by the Combined Administration of DNA, NYVAC and Env Protein-Based Vaccine Candidates: The AUP512 Study

Comparative Immunogenicity of COVID-19 Vaccines in a Population-Based Cohort Study with SARS-CoV-2-Infected and Uninfected Participants

Heterologous Combination of VSV-GP and NYVAC Vectors Expressing HIV-1 Trimeric gp145 Env as Vaccination Strategy to Induce Balanced B and T Cell Immune Responses

Computationally designed Spike antigens induce neutralising responses against the breadth of SARS-COV-2 variants

Targeting HIV-1 Env gp140 to LOX-1 Elicits Immune Responses in Rhesus Macaques

Dürfen wir noch auf eine HIV-Impfung hoffen?

Influenza A (N1-N9) and Influenza B (B/Victoria and B/Yamagata) Neuraminidase Pseudotypes as Tools for Pandemic Preparedness and Improved Influenza Vaccine Design

Exploiting Pan Influenza A and Pan Influenza B Pseudotype Libraries for Efficient Vaccine Antigen Selection

Wann kommt endlich eine Impfung gegen HIV?

Particle-based delivery of the HIV envelope protein

Particle-based delivery of the HIV envelope protein

A serum-stable RNA aptamer specific for SARS-CoV-2 neutralizes viral entry

Development of a vaccine against HIV: is this aim accomplishable?

Interplay of Promoter Usage and Intragenic CpG Content: Impact on GFP Reporter Gene Expression

SARS-CoV-2 Spike Protein Stabilized in the Closed State Induces Potent Neutralizing Responses

Suchergebnisse filtern